
    
      The primary goals of the trial are:

        -  To show a survival increase at hospital admittance after out-of-hospital cardiac arrest
           of patients treated by continuous chest compressions LUCAS device compared with patients
           treated by manual chest compressions.

        -  To evaluate neurological outcome on hospital discharge, in two centres (Vall d'Hebron
           Hospital and Josep Trueta Hospital).
    
  